Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Net Income towards Common Stockholders came in at -$13.1 million in Q1 2026, down 111.08% year-on-year from $118.4 million in Q1 2025, and down 14.79% on a QoQ basis from -$11.4 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$13.1 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 111.08% year-over-year to -$13.1 million in Q1 2026; TTM through Mar 2026 was -$36.6 million, a 38.67% decrease from a year earlier, with the FY2025 full-year figure at -$29.7 million, changed 0.35% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$13.1 million, down from -$11.4 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for CWBHF reached as high as $2.8 million in Q2 2023 and fell as low as -$35.2 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$9.2 million across 5 years, with a median of -$7.9 million in 2022.
- Across the five-year window, Net Income towards Common Stockholders tumbled 876.58% in 2022 and soared 136.14% in 2023, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$35.2 million in 2022, then jumped by 75.63% to -$8.6 million in 2023, then soared by 60.77% to -$3.4 million in 2024, then plunged by 239.16% to -$11.4 million in 2025, then dropped by 14.79% to -$13.1 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$13.1 million in Q1 2026, -$11.4 million in Q4 2025, and -$5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -13.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -11.42 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -6.21 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -11.06 Mn |
| Mar 31, 2024 | -9.63 Mn |
| Dec 31, 2023 | -8.59 Mn |
| Sep 30, 2023 | -15.14 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | -35.23 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -118.25 Mn |
| Sep 30, 2021 | -777,000.00 |
| Jun 30, 2021 | -5.92 Mn |